DCF — BAPTIST HEALTH LOUISVILLE
Enterprise Value: $-802.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-802.5M
Enterprise Value
$-260.4M
PV of Cash Flows
$-542.0M
PV of Terminal Value
$-872.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $697.4M | $-46.4M | -7.0% | $-75.9M | $-69.0M |
| Year 2 | $718.3M | $-40.6M | -6.0% | $-71.0M | $-58.7M |
| Year 3 | $739.9M | $-34.4M | -5.0% | $-65.8M | $-49.4M |
| Year 4 | $762.1M | $-31.7M | -4.0% | $-63.9M | $-43.7M |
| Year 5 | $785.0M | $-30.6M | -4.0% | $-63.9M | $-39.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-802.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$677.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07154158884671234
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5